2,413
Views
62
CrossRef citations to date
0
Altmetric
Review

Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics

, , &
Pages 399-408 | Published online: 09 Jan 2014

Figures & data

Figure 1. General schema of photolabeling–mass spectrometry experiments.

(A)Following interaction of the protein of interest with a photolabeled ligand, the complex is covalently linked by UV irradiation. Isolation of the covalent complex followed by MS allows for identification of binding protein, determination of the ligand:protein stoichiometry, and identification and sequencing of the ligand-binding region of the protein. We used this approach to localize the binding site for an inhibitor of the HIV-1 integrase protein. (B) Alternatively, if the receptor protein is known, the purified protein may be subjected to direct LC-MS following ligand binding, crosslinking and tryptic digestion. This approach may be advantageous when dealing with hydrophobic ligands that may be lost during HPLC separation.

HPLC: High-performance liquid chomatography; LC: Liquid chromatography; MALDI: Matrix-assisted laser desorption/ionization; MS: Mass spectrometry; UV: Ultraviolet.

Figure 1. General schema of photolabeling–mass spectrometry experiments.(A)Following interaction of the protein of interest with a photolabeled ligand, the complex is covalently linked by UV irradiation. Isolation of the covalent complex followed by MS allows for identification of binding protein, determination of the ligand:protein stoichiometry, and identification and sequencing of the ligand-binding region of the protein. We used this approach to localize the binding site for an inhibitor of the HIV-1 integrase protein. (B) Alternatively, if the receptor protein is known, the purified protein may be subjected to direct LC-MS following ligand binding, crosslinking and tryptic digestion. This approach may be advantageous when dealing with hydrophobic ligands that may be lost during HPLC separation.HPLC: High-performance liquid chomatography; LC: Liquid chromatography; MALDI: Matrix-assisted laser desorption/ionization; MS: Mass spectrometry; UV: Ultraviolet.
Figure 2. Deconvoluted ESI-MS spectra of (left panel) HIV-integrase and (right panel) HIV-integrase after photoaffinity labeling with the HIV-integrase inhibitor coumarin (R61).

(A): the base peak at m/z 19,954 agrees precisely with the MW of HIV-integrase as calculated from the amino acid sequence. The additional peaks at higher m/z can be assigned to oxidation products and β-mercaptoethanol adducts. (B): due to the presence of the photoaffinity label, the peaks are shifted to higher m/z values by 516 Da, which agrees precisely with the expected mass increment for addition of one coumarin molecule.

ESI: Electrospray ionization; MS: Mass spectrometry; MW: Molecular weight.

Figure 2. Deconvoluted ESI-MS spectra of (left panel) HIV-integrase and (right panel) HIV-integrase after photoaffinity labeling with the HIV-integrase inhibitor coumarin (R61).(A): the base peak at m/z 19,954 agrees precisely with the MW of HIV-integrase as calculated from the amino acid sequence. The additional peaks at higher m/z can be assigned to oxidation products and β-mercaptoethanol adducts. (B): due to the presence of the photoaffinity label, the peaks are shifted to higher m/z values by 516 Da, which agrees precisely with the expected mass increment for addition of one coumarin molecule.ESI: Electrospray ionization; MS: Mass spectrometry; MW: Molecular weight.
Figure 3. Model of a single HIV integrase dimer rendered by helix.

Yellow represents the inhibitor binding region peptide 128AACWWAGIK136. Blue represents one molecule of the coumarin inhibitor complexed within the binding site determined by PAL-MS. Cyan represents the integrase active site residues (DDE motif) and the sphere is Mg2+ chelating at this site.

MS: Mass spectrometry; PAL: Photoaffinity labeling.

Figure 3. Model of a single HIV integrase dimer rendered by helix.Yellow represents the inhibitor binding region peptide 128AACWWAGIK136. Blue represents one molecule of the coumarin inhibitor complexed within the binding site determined by PAL-MS. Cyan represents the integrase active site residues (DDE motif) and the sphere is Mg2+ chelating at this site.MS: Mass spectrometry; PAL: Photoaffinity labeling.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.